Practical Strategies for Ensuring a Diverse Patient Population in Clinical Trials

Clinical trials are becoming more complex. The number of endpoints, procedures, and sites used per study have all increased. This makes recruiting patients — and particularly diverse patients — more difficult.

Discover more by downloading the White Paper.

PDF preview of White Paper available for download.
Citeline may contact you about relevant products, services and content. To opt-out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.

Thank you.




Your download should open in a new window. You can also manually download by clicking the button below.



The ultimate goal is a world that has better health equity, so that anybody, regardless of who they are, how they’re educated, the color of their skin, their age, their ethnicity, their socioeconomic status, their geography, has the same level of access to a particular drug.
Claire Riches, Head of Clinical Solutions, Citeline

Related resources

''
SEP 20, 2024
Infographic
Regulatory & Compliance

What US FDA Is Expecting and When

See what the US FDA is expecting from diversity action plans and when this might be implemented.

A female scientist in a lab coat holds a tube, conducting experiments in a laboratory setting.
MAY 07, 2024
Article
Clinical

Diversity at the Start: Best Practices for Clinical Trial Planning

Study sponsors should begin their clinical trial diversity efforts with a fit-for-purpose clinical protocol.

Man exploring options for a diverse clinical trial.
MAY 29, 2024
Article
Clinical

Practical Approaches to Clinical Trial Diversity

Learn best practices in increasing diversity in clinical trials. Experts from GSK, Pfizer, AbbVie, and Bristol Myers Squibb discuss their multipronged approaches.